Scleroderma. 2. Incidence of systemic disturbance and assessment of possible aetiological factors.
D001847:Bone Diseases / Q000150:complications; D002114:Calcinosis / Q000150:complications; D003490:Cyanosis / Q000150:complications; D005243:Feces / Q000032:analysis; D005260:Female; D005767:Gastrointestinal Diseases / Q000150:complications; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D008055:Lipids / Q000032:analysis; D008107:Liver Diseases / Q000150:complications; D008297:Male; D009506:Nevus / Q000150:complications; D011928:Raynaud Disease / Q000150:complications; D012595:Scleroderma, Systemic / Q000145:classification / Q000209:etiology* / Q000276:immunology; D012859:Sjogren's Syndrome / Q000150:complications; D012871:Skin Diseases / Q000150:complications; D014456:Ulcer / Q000150:complications; D014570:Urologic Diseases / Q000150:complications; D014652:Vascular Diseases / Q000150:complications
D008055:Lipids